First-Line Treatment for Common Sexually Transmitted Infections
For chlamydia, use doxycycline 100 mg orally twice daily for 7 days as first-line therapy; for gonorrhea, use ceftriaxone 500 mg IM (≥150 kg body weight) or 250 mg IM (<150 kg); for syphilis, use penicillin G benzathine 2.4 million units IM; for trichomoniasis, use metronidazole 500 mg orally twice daily for 7 days; for genital herpes, use antivirals for symptomatic episodes; and for genital warts, use patient-applied imiquimod or provider-applied cryotherapy.
Chlamydia (Chlamydia trachomatis)
Recommended First-Line Treatment:
- Doxycycline 100 mg orally twice daily for 7 days 1
- Alternative: Azithromycin 1 g orally as a single dose 2, 3, 4, 5
Key Clinical Points:
- Doxycycline is now preferred over azithromycin due to superior efficacy and concerns about Mycoplasma genitalium resistance to macrolides 1
- Azithromycin remains useful when compliance with 7-day regimens is questionable or for directly observed therapy 2, 4, 5
- Both regimens have cure rates of 97-98% in clinical trials 5
- Patients must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 2, 4
Additional Alternatives:
- Levofloxacin 500 mg orally once daily for 7 days 3, 4, 5
- Ofloxacin 300 mg orally twice daily for 7 days 2, 4, 5
- Erythromycin base 500 mg orally four times daily for 7 days (less effective, more GI side effects) 2, 4, 5
Important Caveats:
- Test-of-cure for rectal chlamydia if treated with azithromycin 1
- Rescreen all women approximately 3 months after treatment due to high reinfection rates 4, 5
- Coinfection with gonorrhea is common; treat presumptively for both when gonorrhea is diagnosed 2, 6
Gonorrhea (Neisseria gonorrhoeae)
Recommended First-Line Treatment:
- Ceftriaxone 500 mg IM as a single dose for patients weighing ≥150 kg 1
- Ceftriaxone 250 mg IM as a single dose for patients weighing <150 kg 1
- PLUS treatment for chlamydia (doxycycline 100 mg orally twice daily for 7 days) due to high coinfection rates 7, 1
Key Clinical Points:
- Ceftriaxone monotherapy is now recommended (no longer requires dual therapy with azithromycin) 1
- Weight-based dosing reflects updated 2021 CDC guidelines 1
- Increasing antimicrobial resistance limits oral treatment options 8, 9
Pharyngeal Gonorrhea:
- Same ceftriaxone dosing as above 2
- Test-of-cure is mandatory for all pharyngeal gonorrhea cases 1
- Pharyngeal infections are more difficult to eradicate than urogenital infections 2
Alternative Regimens (if ceftriaxone unavailable):
- Cefixime 800 mg orally as a single dose (less effective than ceftriaxone) 2
- Spectinomycin 2 g IM (not available in US; useful for cephalosporin allergy; ineffective for pharyngeal infection) 2
Critical Management Points:
- Patients should abstain from sexual intercourse until therapy completed and partners treated 2
- Partner notification and treatment within 60 days of symptom onset 2
- Fluoroquinolones (ciprofloxacin, ofloxacin) are no longer recommended due to widespread resistance 2, 8
Syphilis (Treponema pallidum)
Primary, Secondary, or Early Latent Syphilis (<1 year duration):
- Penicillin G benzathine 2.4 million units IM as a single dose 1
Late Latent Syphilis or Unknown Duration (>1 year):
- Penicillin G benzathine 2.4 million units IM weekly for 3 consecutive weeks 1
Neurosyphilis, Ocular, or Otic Syphilis:
- Aqueous crystalline penicillin G 18-24 million units IV daily (administered as 3-4 million units IV every 4 hours or continuous infusion) for 10-14 days 1
Key Clinical Points:
- Penicillin remains the only proven effective treatment for syphilis 9
- Thorough evaluation for neurologic, ophthalmic, and otic symptoms is essential at any stage 1
- These complications can occur at any stage and require IV penicillin therapy 1
Screening Recommendations:
- Screen all pregnant women three times: first prenatal visit, third trimester, and at delivery 10
- Screen persons living in counties with primary/secondary syphilis rates >4.6 per 100,000 (Healthy People 2030 threshold) 10
Penicillin Allergy:
- Desensitization is required for pregnant women 3
- Alternative regimens exist for non-pregnant patients but are less well-studied 3
Trichomoniasis (Trichomonas vaginalis)
Recommended First-Line Treatment:
- Metronidazole 500 mg orally twice daily for 7 days 1
- Alternative: Metronidazole 2 g orally as a single dose 7
- Alternative: Tinidazole 2 g orally as a single dose 7
Key Clinical Points:
- The 7-day metronidazole regimen is now preferred over single-dose therapy 1
- Approximately 70% of trichomoniasis infections are asymptomatic 8
- Patients should abstain from alcohol during treatment and for 24 hours after metronidazole or 72 hours after tinidazole 7
Important Management:
- Treat sexual partners simultaneously 7
- If alcohol recently ingested or emergency contraception provided, can take medication at home rather than directly observed 7
Genital Herpes (HSV-1 and HSV-2)
First Clinical Episode:
- Acyclovir 400 mg orally three times daily for 7-10 days 11
- Valacyclovir 1 g orally twice daily for 7-10 days 11
- Famciclovir 250 mg orally three times daily for 7-10 days 11
Recurrent Episodes:
- Acyclovir 800 mg orally twice daily for 5 days 11
- Valacyclovir 500 mg orally twice daily for 3 days 11
- Famciclovir 1 g orally twice daily for 1 day 11
Suppressive Therapy (for frequent recurrences):
- Acyclovir 400 mg orally twice daily 11
- Valacyclovir 500-1000 mg orally once daily 11
- Famciclovir 250 mg orally twice daily 11
Key Clinical Points:
- No cure is available for genital herpes 8
- Early initiation of therapy reduces duration of illness and may prevent complications including urinary retention, meningism, or severe systemic illness 11
- Rates of HSV-1 and HSV-2 have declined in the US from 1999-2016 8
- Nucleic acid amplification tests have high sensitivity (86.1-100%) and specificity (97.1-100%) for symptomatic HSV 8
Genital Warts (HPV types 6 and 11)
Patient-Applied Treatments:
- Imiquimod 5% cream applied once daily at bedtime, three times per week for up to 16 weeks 12
- Podofilox 0.5% solution or gel applied twice daily for 3 days, followed by 4 days off therapy, repeated for up to 4 cycles 12
- Sinecatechins 15% ointment (green tea extract catechins) applied three times daily for up to 16 weeks 12
Provider-Applied Treatments:
- Cryotherapy with liquid nitrogen or cryoprobe, repeated every 1-2 weeks 2
- Podophyllin resin 10-25% in compound tincture of benzoin, applied weekly 2
- Trichloroacetic acid (TCA) 80-90% applied weekly 2
- Surgical removal (excision, electrocautery, laser) 2
Key Clinical Points:
- Sinecatechins is a newer patient-applied option added to 2010 CDC guidelines 12
- No single treatment is ideal for all patients or all warts 2
- Visible genital warts are usually caused by HPV types 6 or 11, which are not associated with cervical cancer 2
- HPV vaccine (quadrivalent or bivalent) is recommended for prevention 12
Mycoplasma genitalium
Recommended Treatment:
- Moxifloxacin 400 mg orally once daily for 7-14 days 9, 10
- Alternative: Doxycycline 100 mg orally twice daily for 7 days followed by moxifloxacin 400 mg orally once daily for 7 days 10
Key Clinical Points:
- High resistance to macrolides (azithromycin) limits treatment options 8, 9
- Fluoroquinolones like moxifloxacin are increasingly required 8, 9
- Testing and treatment guidance continues to evolve 10
Sexual Assault Prophylaxis
Recommended Empiric Regimen:
- Ceftriaxone 250 mg IM single dose PLUS Azithromycin 1 g orally single dose PLUS Metronidazole 2 g orally single dose (or Tinidazole 2 g orally single dose) 7
- Emergency contraception should be considered 7
- Hepatitis B vaccination if not previously vaccinated 7
- HPV vaccination for females aged 9-26 years and males aged 9-21 years (through age 26 for MSM) 7
Rationale: